Follow
Anand Gururajan, PhD
Anand Gururajan, PhD
Verified email at sydney.edu.au - Homepage
Title
Cited by
Cited by
Year
The future of rodent models in depression research
A Gururajan, A Reif, JF Cryan, DA Slattery
Nature Reviews Neuroscience 20 (11), 686-701, 2019
2352019
Molecular biomarkers of Depression
A Gururajan, G Clarke, TG Dinan, JF Cryan
Neuroscience & Biobehavioral Reviews, 2016
1492016
Effect of cannabidiol in a MK-801-rodent model of aspects of schizophrenia
A Gururajan, DA Taylor, DT Malone
Behavioural brain research 222 (2), 299-308, 2011
1192011
MicroRNAs as biomarkers for major depression: a role for let-7b and let-7c
A Gururajan, ME Naughton, KA Scott, RM O'connor, G Moloney, G Clarke, ...
Translational psychiatry 6 (8), e862-e862, 2016
1162016
Is the mTOR‐signalling cascade disrupted in Schizophrenia?
A Gururajan, M van den Buuse
Journal of neurochemistry 129 (3), 377-387, 2014
962014
Cannabidiol and clozapine reverse MK-801-induced deficits in social interaction and hyperactivity in Sprague–Dawley rats
A Gururajan, DA Taylor, DT Malone
Journal of psychopharmacology 26 (10), 1317-1332, 2012
862012
Drugs of abuse and increased risk of psychosis development
A Gururajan, EE Manning, M Klug, M van den Buuse
Australian & New Zealand Journal of Psychiatry 46 (12), 1120-1135, 2012
762012
Volatility as a concept to understand the impact of stress on the microbiome
TFS Bastiaanssen, A Gururajan, M van de Wouw, GM Moloney, NL Ritz, ...
Psychoneuroendocrinology 124, 105047, 2021
682021
Does cannabidiol have a role in the treatment of schizophrenia?
A Gururajan, DT Malone
Schizophrenia research 176 (2-3), 281-290, 2016
642016
Current pharmacological models of social withdrawal in rats: relevance to schizophrenia
A Gururajan, DA Taylor, DT Malone
Behavioural pharmacology 21 (8), 690-709, 2010
622010
All roads lead to the miRNome: miRNAs have a central role in the molecular pathophysiology of psychiatric disorders
RM O’Connor, A Gururajan, TG Dinan, PJ Kenny, JF Cryan
Trends in pharmacological sciences 37 (12), 1029-1044, 2016
602016
Resilience to chronic stress is associated with specific neurobiological, neuroendocrine and immune responses
A Gururajan, M van de Wouw, M Boehme, T Becker, R O'Connor, ...
Brain, Behavior, and Immunity 80, 583-594, 2019
572019
Brain-derived neurotrophic factor heterozygous mutant rats show selective cognitive changes and vulnerability to chronic corticosterone treatment
A Gururajan, RA Hill, M van den Buuse
Neuroscience 284, 297-310, 2015
372015
Cannabidiol disrupts conditioned fear expression and cannabidiolic acid reduces trauma-induced anxiety-related behaviour in mice
N Assareh, A Gururajan, C Zhou, JL Luo, RC Kevin, JC Arnold
Behavioural pharmacology 31 (6), 591-596, 2020
322020
Effect of testing conditions on the propsychotic action of MK-801 on prepulse inhibition, social behaviour and locomotor activity
A Gururajan, DA Taylor, DT Malone
Physiology & behavior 99 (1), 131-138, 2010
292010
Long-term differential effects of chronic young-adult corticosterone exposure on anxiety and depression-like behaviour in BDNF heterozygous rats depend on the experimental …
A Gururajan, R Hill, M van den Buuse
Neuroscience letters 576, 6-10, 2014
192014
A comprehensive approach to modeling maternal immune activation in rodents
MC Bucknor, A Gururajan, RC Dale, MJ Hofer
Frontiers in neuroscience 16, 1071976, 2022
142022
Acute alcohol exposure dose-dependently alleviates social avoidance in adolescent mice and inhibits social investigation in adult mice
JS Raymond, BB Wilson, O Tan, A Gururajan, MT Bowen
Psychopharmacology 236, 3625-3639, 2019
122019
The impact of psychosocial defeat stress on the bed nucleus of the stria terminalis transcriptome in adult male mice
A Gururajan, TFS Bastiaanssen, AP Ventura Silva, GM Moloney, JF Cryan
European Journal of Neuroscience 55 (1), 67-77, 2022
9*2022
Sex differences in susceptibility to depression: a role for LncRNAs
A Gururajan
Neuron 106 (6), 871-872, 2020
82020
The system can't perform the operation now. Try again later.
Articles 1–20